Planning pivotal studies with confidence
Learn how one AI-powered platform connects two worlds: financial forecasting and feasibility modeling, and designs delivery-ready study plans for your pivotal clinical trial or your entire portfolio.
Presenters:
- Emily McInturf, Director of Feasibility
- Alla Smyshlyaeva, Head of Proposals and Market Growth
Webinar Details
Clinical trials hinge on accurate planning. Granted, you can’t predict a black swan, but you can proactively assess known risks and plan your costs – all in one place. Advanced AI models, when paired with operational and therapeutic expertise, can reduce uncertainty before your study begins. You’ll see how our methodology helps you:
- Optimize site and country selection based on site performance Quickly identify similar protocols using real-world data instead of relying on high-level data and often inaccurate industry benchmarks
- Model and compare hundreds of potential enrollment scenarios, their budgets, and likelihoods of success within only a few minutes
- Optimize site and country selection based on site performance
- Develop – in real time – full study budgets, with cash flows, for each study plan
We’ll also introduce how PSI is integrating this approach with the first-of-its-kind semantic knowledge layer, enabling even richer insights. Join us to learn how to turn data, not just intuition, into stronger, more reliable clinical trial plans.
Speakers
Emily McInturf
Director of Feasibility
Emily McInturf, Director of Feasibility, has spent the past 15 years working in the clinical research industry. As a leader within PSI’s global feasibility team, Emily specializes in strategy development across multiple therapeutic areas, focusing on aligning a study’s design with top–enrolling investigators in the right countries. As a director, Emily provides oversight for global feasibility and site identification activities for both pre- and post-award opportunities and projects.
Alla Smyshlyaeva
Head of Proposals and Market Growth
Alla Smyshlyaeva, MBA, leads the proposal and marketing teams at PSI CRO. With PSI since 2005, Alla has overseen the development of some of the company’s key initiatives, including but not limited to strategic proposals, knowledge management, vendor management, and clinical trial planning platform, INTELIA™.
